Logo image of ALBFR.PA

SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

EPA:ALBFR - Euronext Paris - Matif - FR0010202606 - Common Stock - Currency: EUR

258  -5 (-1.9%)

Fundamental Rating

5

ALBFR gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 99 industry peers in the Software industry. ALBFR has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALBFR is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ALBFR was profitable.
In the past year ALBFR had a positive cash flow from operations.
In the past 5 years ALBFR has always been profitable.
Each year in the past 5 years ALBFR had a positive operating cash flow.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

1.2 Ratios

The Return On Assets of ALBFR (0.01%) is comparable to the rest of the industry.
ALBFR has a Return On Equity of 0.02%. This is comparable to the rest of the industry: ALBFR outperforms 46.46% of its industry peers.
ALBFR's Return On Invested Capital of 0.01% is in line compared to the rest of the industry. ALBFR outperforms 45.45% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALBFR is below the industry average of 11.50%.
The 3 year average ROIC (8.93%) for ALBFR is well above the current ROIC(0.01%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.01%
ROE 0.02%
ROIC 0.01%
ROA(3y)7.47%
ROA(5y)7.71%
ROE(3y)16.93%
ROE(5y)15.91%
ROIC(3y)8.93%
ROIC(5y)9.55%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 14.82%, ALBFR is in the better half of the industry, outperforming 70.71% of the companies in the same industry.
In the last couple of years the Profit Margin of ALBFR has grown nicely.
Looking at the Operating Margin, with a value of 11.66%, ALBFR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Operating Margin of ALBFR has grown nicely.
With a Gross Margin value of 73.74%, ALBFR perfoms like the industry average, outperforming 58.59% of the companies in the same industry.
In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 11.66%
PM (TTM) 14.82%
GM 73.74%
OM growth 3Y2.95%
OM growth 5Y6.35%
PM growth 3Y3.22%
PM growth 5Y7.3%
GM growth 3Y1.55%
GM growth 5Y2.42%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALBFR is still creating some value.
Compared to 1 year ago, ALBFR has more shares outstanding
ALBFR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALBFR has been reduced compared to a year ago.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ALBFR has an Altman-Z score of 0.86. This is a bad value and indicates that ALBFR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.86, ALBFR is not doing good in the industry: 70.71% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALBFR is 1392.17, which is on the high side as it means it would take ALBFR, 1392.17 years of fcf income to pay off all of its debts.
ALBFR's Debt to FCF ratio of 1392.17 is in line compared to the rest of the industry. ALBFR outperforms 41.41% of its industry peers.
ALBFR has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
ALBFR has a Debt to Equity ratio (0.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 1392.17
Altman-Z 0.86
ROIC/WACC0
WACC7.9%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.40 indicates that ALBFR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.40, ALBFR is in line with its industry, outperforming 56.57% of the companies in the same industry.
ALBFR has a Quick Ratio of 1.40. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
ALBFR's Quick ratio of 1.40 is fine compared to the rest of the industry. ALBFR outperforms 62.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

8

3. Growth

3.1 Past

ALBFR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 111.54%, which is quite impressive.
The Earnings Per Share has been growing by 19.75% on average over the past years. This is quite good.
Looking at the last year, ALBFR shows a quite strong growth in Revenue. The Revenue has grown by 19.75% in the last year.
Measured over the past years, ALBFR shows a quite strong growth in Revenue. The Revenue has been growing by 12.69% on average per year.
EPS 1Y (TTM)111.54%
EPS 3Y16.52%
EPS 5Y19.75%
EPS Q2Q%64.91%
Revenue 1Y (TTM)19.75%
Revenue growth 3Y14.45%
Revenue growth 5Y12.69%
Sales Q2Q%18.83%

3.2 Future

Based on estimates for the next years, ALBFR will show a very strong growth in Earnings Per Share. The EPS will grow by 24.77% on average per year.
The Revenue is expected to grow by 19.15% on average over the next years. This is quite good.
EPS Next Y52.19%
EPS Next 2Y29.04%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue Next Year25.02%
Revenue Next 2Y21.49%
Revenue Next 3Y19.15%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

ALBFR is valuated quite expensively with a Price/Earnings ratio of 54.78.
The rest of the industry has a similar Price/Earnings ratio as ALBFR.
When comparing the Price/Earnings ratio of ALBFR to the average of the S&P500 Index (29.35), we can say ALBFR is valued expensively.
Based on the Price/Forward Earnings ratio of 43.94, the valuation of ALBFR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBFR is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, ALBFR is valued quite expensively.
Industry RankSector Rank
PE 54.78
Fwd PE 43.94
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ALBFR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 58.37
EV/EBITDA -2105.99
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5K 10K 15K 20K

4.3 Compensation for Growth

ALBFR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ALBFR has a very decent profitability rating, which may justify a higher PE ratio.
ALBFR's earnings are expected to grow with 24.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.05
PEG (5Y)2.77
EPS Next 2Y29.04%
EPS Next 3Y24.77%

0

5. Dividend

5.1 Amount

No dividends for ALBFR!.
Industry RankSector Rank
Dividend Yield N/A

SIDETRADE

EPA:ALBFR (3/7/2025, 7:00:00 PM)

258

-5 (-1.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-17 2024-10-17
Earnings (Next)03-26 2025-03-26/amc
Inst Owners20.96%
Inst Owner ChangeN/A
Ins Owners36%
Ins Owner ChangeN/A
Market Cap379.26M
Analysts84
Price Target275.4 (6.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.55
Dividend Growth(5Y)14.53%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 54.78
Fwd PE 43.94
P/S 7.96
P/FCF 58.37
P/OCF 38.01
P/B 0.01
P/tB 0.1
EV/EBITDA -2105.99
EPS(TTM)4.71
EY1.83%
EPS(NY)5.87
Fwd EY2.28%
FCF(TTM)4.42
FCFY1.71%
OCF(TTM)6.79
OCFY2.63%
SpS32.43
BVpS24046.23
TBVpS2704.61
PEG (NY)1.05
PEG (5Y)2.77
Profitability
Industry RankSector Rank
ROA 0.01%
ROE 0.02%
ROCE 0.01%
ROIC 0.01%
ROICexc 0.02%
ROICexgc N/A
OM 11.66%
PM (TTM) 14.82%
GM 73.74%
FCFM 13.63%
ROA(3y)7.47%
ROA(5y)7.71%
ROE(3y)16.93%
ROE(5y)15.91%
ROIC(3y)8.93%
ROIC(5y)9.55%
ROICexc(3y)18.77%
ROICexc(5y)19.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.16%
ROCE(5y)12.99%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-7.59%
ROICexc growth 5Y9.65%
OM growth 3Y2.95%
OM growth 5Y6.35%
PM growth 3Y3.22%
PM growth 5Y7.3%
GM growth 3Y1.55%
GM growth 5Y2.42%
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 1392.17
Debt/EBITDA 1309.81
Cap/Depr 257.97%
Cap/Sales 7.3%
Interest Coverage 250
Cash Conversion 144.47%
Profit Quality 91.99%
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z 0.86
F-Score5
WACC7.9%
ROIC/WACC0
Cap/Depr(3y)266.18%
Cap/Depr(5y)257.15%
Cap/Sales(3y)4.95%
Cap/Sales(5y)4.41%
Profit Quality(3y)103.59%
Profit Quality(5y)116.34%
High Growth Momentum
Growth
EPS 1Y (TTM)111.54%
EPS 3Y16.52%
EPS 5Y19.75%
EPS Q2Q%64.91%
EPS Next Y52.19%
EPS Next 2Y29.04%
EPS Next 3Y24.77%
EPS Next 5YN/A
Revenue 1Y (TTM)19.75%
Revenue growth 3Y14.45%
Revenue growth 5Y12.69%
Sales Q2Q%18.83%
Revenue Next Year25.02%
Revenue Next 2Y21.49%
Revenue Next 3Y19.15%
Revenue Next 5YN/A
EBIT growth 1Y49.13%
EBIT growth 3Y17.83%
EBIT growth 5Y19.84%
EBIT Next Year34.52%
EBIT Next 3Y24%
EBIT Next 5YN/A
FCF growth 1Y-3.58%
FCF growth 3Y-6.57%
FCF growth 5YN/A
OCF growth 1Y28.12%
OCF growth 3Y4.29%
OCF growth 5Y58.85%